AKT1 and cancer: Several mechanisms have been implicated in TKI resistance in HCC, including activation of EGFR, PI3K/AKT, MAPK, and JAK/STAT3 pathways, EMT, hypoxia, cancer cell stemness and metabolic reprogramming [38, 39].